[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2015-2027 Global mRNA Vaccines & Therapeutics Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

April 2020 | 130 pages | ID: 26FE14F1136CEN
Maia Research

US$ 3,460.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The worldwide market for mRNA Vaccines & Therapeutics is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
Novartis
Janssen
Intellia Therapeutics
Roche Custom Biotech
RaNa Therapeutics
MaxCyte
CRISPR Therapeutics
AstraZeneca
PhaseRx
Kernal Biologics
GlaxoSmithKline Vaccines
Argos Therapeutics
Boehringer Ingelheim
ETheRNA immunotherapies
Precision NanoSystems
Bayer
In-Cell-Art
Moderna Therapeutics
Ethris
CureVac
BioNTech


Major Types Covered
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine

Major Applications Covered
Hospital
Clinic
Others

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global mRNA Vaccines & Therapeutics Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the mRNA Vaccines & Therapeutics Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE MRNA VACCINES & THERAPEUTICS MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL MRNA VACCINES & THERAPEUTICS MARKET-SEGMENTATION BY TYPE

5.1 Standardization Of Cancer Treatment MRNA Vaccine
5.2 Individualized Cancer Treatment MRNA Vaccine
5.3 Infectious Disease Treatment MRNA Vaccine
5.4 Infection Prevention MRNA Vaccine

6 GLOBAL MRNA VACCINES & THERAPEUTICS MARKET-SEGMENTATION BY APPLICATION

6.1 Hospital
6.2 Clinic
6.3 Others

7 GLOBAL MRNA VACCINES & THERAPEUTICS MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 Novartis
  8.1.1 Novartis Profile
  8.1.2 Novartis Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 Novartis Product/Solution Launches and Enhancements Analysis
  8.1.4 Novartis Business Overview/Recent Development/Acquisitions
8.2 Janssen
  8.2.1 Janssen Profile
  8.2.2 Janssen Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Janssen Product/Solution Launches and Enhancements Analysis
  8.2.4 Janssen Business Overview/Recent Development/Acquisitions
8.3 Intellia Therapeutics
  8.3.1 Intellia Therapeutics Profile
  8.3.2 Intellia Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Intellia Therapeutics Product/Solution Launches and Enhancements Analysis
  8.3.4 Intellia Therapeutics Business Overview/Recent Development/Acquisitions
8.4 Roche Custom Biotech
  8.4.1 Roche Custom Biotech Profile
  8.4.2 Roche Custom Biotech Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Roche Custom Biotech Product/Solution Launches and Enhancements Analysis
  8.4.4 Roche Custom Biotech Business Overview/Recent Development/Acquisitions
8.5 RaNa Therapeutics
  8.5.1 RaNa Therapeutics Profile
  8.5.2 RaNa Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 RaNa Therapeutics Product/Solution Launches and Enhancements Analysis
  8.5.4 RaNa Therapeutics Business Overview/Recent Development/Acquisitions
8.6 MaxCyte
  8.6.1 MaxCyte Profile
  8.6.2 MaxCyte Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 MaxCyte Product/Solution Launches and Enhancements Analysis
  8.6.4 MaxCyte Business Overview/Recent Development/Acquisitions
8.7 CRISPR Therapeutics
  8.7.1 CRISPR Therapeutics Profile
  8.7.2 CRISPR Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 CRISPR Therapeutics Product/Solution Launches and Enhancements Analysis
  8.7.4 CRISPR Therapeutics Business Overview/Recent Development/Acquisitions
8.8 AstraZeneca
  8.8.1 AstraZeneca Profile
  8.8.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 AstraZeneca Product/Solution Launches and Enhancements Analysis
  8.8.4 AstraZeneca Business Overview/Recent Development/Acquisitions
8.9 PhaseRx
  8.9.1 PhaseRx Profile
  8.9.2 PhaseRx Sales, Growth Rate and Global Market Share from 2015-2020
  8.9.3 PhaseRx Product/Solution Launches and Enhancements Analysis
  8.9.4 PhaseRx Business Overview/Recent Development/Acquisitions
8.10 Kernal Biologics
  8.10.1 Kernal Biologics Profile
  8.10.2 Kernal Biologics Sales, Growth Rate and Global Market Share from 2015-2020
  8.10.3 Kernal Biologics Product/Solution Launches and Enhancements Analysis
  8.10.4 Kernal Biologics Business Overview/Recent Development/Acquisitions
8.11 GlaxoSmithKline Vaccines
  8.11.1 GlaxoSmithKline Vaccines Profile
  8.11.2 GlaxoSmithKline Vaccines Sales, Growth Rate and Global Market Share from 2015-2020
  8.11.3 GlaxoSmithKline Vaccines Product/Solution Launches and Enhancements Analysis
  8.11.4 GlaxoSmithKline Vaccines Business Overview/Recent Development/Acquisitions
8.12 Argos Therapeutics
  8.12.1 Argos Therapeutics Profile
  8.12.2 Argos Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
  8.12.3 Argos Therapeutics Product/Solution Launches and Enhancements Analysis
  8.12.4 Argos Therapeutics Business Overview/Recent Development/Acquisitions
8.13 Boehringer Ingelheim
  8.13.1 Boehringer Ingelheim Profile
  8.13.2 Boehringer Ingelheim Sales, Growth Rate and Global Market Share from 2015-2020
  8.13.3 Boehringer Ingelheim Product/Solution Launches and Enhancements Analysis
  8.13.4 Boehringer Ingelheim Business Overview/Recent Development/Acquisitions
8.14 ETheRNA immunotherapies
  8.14.1 ETheRNA immunotherapies Profile
  8.14.2 ETheRNA immunotherapies Sales, Growth Rate and Global Market Share from 2015-2020
  8.14.3 ETheRNA immunotherapies Product/Solution Launches and Enhancements Analysis
  8.14.4 ETheRNA immunotherapies Business Overview/Recent Development/Acquisitions
8.15 Precision NanoSystems
  8.15.1 Precision NanoSystems Profile
  8.15.2 Precision NanoSystems Sales, Growth Rate and Global Market Share from 2015-2020
  8.15.3 Precision NanoSystems Product/Solution Launches and Enhancements Analysis
  8.15.4 Precision NanoSystems Business Overview/Recent Development/Acquisitions
8.16 Bayer
  8.16.1 Bayer Profile
  8.16.2 Bayer Sales, Growth Rate and Global Market Share from 2015-2020
  8.16.3 Bayer Product/Solution Launches and Enhancements Analysis
  8.16.4 Bayer Business Overview/Recent Development/Acquisitions
8.17 In-Cell-Art
  8.17.1 In-Cell-Art Profile
  8.17.2 In-Cell-Art Sales, Growth Rate and Global Market Share from 2015-2020
  8.17.3 In-Cell-Art Product/Solution Launches and Enhancements Analysis
  8.17.4 In-Cell-Art Business Overview/Recent Development/Acquisitions
8.18 Moderna Therapeutics
  8.18.1 Moderna Therapeutics Profile
  8.18.2 Moderna Therapeutics Sales, Growth Rate and Global Market Share from 2015-2020
  8.18.3 Moderna Therapeutics Product/Solution Launches and Enhancements Analysis
  8.18.4 Moderna Therapeutics Business Overview/Recent Development/Acquisitions
8.19 Ethris
  8.19.1 Ethris Profile
  8.19.2 Ethris Sales, Growth Rate and Global Market Share from 2015-2020
  8.19.3 Ethris Product/Solution Launches and Enhancements Analysis
  8.19.4 Ethris Business Overview/Recent Development/Acquisitions
8.20 CureVac
  8.20.1 CureVac Profile
  8.20.2 CureVac Sales, Growth Rate and Global Market Share from 2015-2020
  8.20.3 CureVac Product/Solution Launches and Enhancements Analysis
  8.20.4 CureVac Business Overview/Recent Development/Acquisitions
8.21 BioNTech
  8.21.1 BioNTech Profile
  8.21.2 BioNTech Sales, Growth Rate and Global Market Share from 2015-2020
  8.21.3 BioNTech Product/Solution Launches and Enhancements Analysis
  8.21.4 BioNTech Business Overview/Recent Development/Acquisitions

9 GLOBAL MRNA VACCINES & THERAPEUTICS MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America mRNA Vaccines & Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America mRNA Vaccines & Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America mRNA Vaccines & Therapeutics Production Analysis from 2015-2020
10.4 North America mRNA Vaccines & Therapeutics Consumption Analysis from 2015-2020
10.5 North America mRNA Vaccines & Therapeutics Import and Export from 2015-2020
10.6 North America mRNA Vaccines & Therapeutics Value, Production and Market Share by Type (2015-2020)
10.7 North America mRNA Vaccines & Therapeutics Consumption, Value and Market Share by Application (2015-2020)
10.8 North America mRNA Vaccines & Therapeutics by Country (United States, Canada)
  10.8.1 North America mRNA Vaccines & Therapeutics Sales by Country (2015-2020)
  10.8.2 North America mRNA Vaccines & Therapeutics Consumption Value by Country (2015-2020)
10.9 North America mRNA Vaccines & Therapeutics Market PEST Analysis

11 EUROPE

11.1 Europe mRNA Vaccines & Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe mRNA Vaccines & Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe mRNA Vaccines & Therapeutics Production Analysis from 2015-2020
11.4 Europe mRNA Vaccines & Therapeutics Consumption Analysis from 2015-2020
11.5 Europe mRNA Vaccines & Therapeutics Import and Export from 2015-2020
11.6 Europe mRNA Vaccines & Therapeutics Value, Production and Market Share by Type (2015-2020)
11.7 Europe mRNA Vaccines & Therapeutics Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe mRNA Vaccines & Therapeutics by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe mRNA Vaccines & Therapeutics Sales by Country (2015-2020)
  11.8.2 Europe mRNA Vaccines & Therapeutics Consumption Value by Country (2015-2020)
11.9 Europe mRNA Vaccines & Therapeutics Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific mRNA Vaccines & Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific mRNA Vaccines & Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific mRNA Vaccines & Therapeutics Production Analysis from 2015-2020
12.4 Asia-Pacific mRNA Vaccines & Therapeutics Consumption Analysis from 2015-2020
12.5 Asia-Pacific mRNA Vaccines & Therapeutics Import and Export from 2015-2020
12.6 Asia-Pacific mRNA Vaccines & Therapeutics Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific mRNA Vaccines & Therapeutics Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific mRNA Vaccines & Therapeutics by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Country (2015-2020)
  12.8.2 Asia-Pacific mRNA Vaccines & Therapeutics Consumption Value by Country (2015-2020)
12.9 Asia-Pacific mRNA Vaccines & Therapeutics Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America mRNA Vaccines & Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America mRNA Vaccines & Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America mRNA Vaccines & Therapeutics Production Analysis from 2015-2020
13.4 Latin America mRNA Vaccines & Therapeutics Consumption Analysis from 2015-2020
13.5 Latin America mRNA Vaccines & Therapeutics Import and Export from 2015-2020
13.6 Latin America mRNA Vaccines & Therapeutics Value, Production and Market Share by Type (2015-2020)
13.7 Latin America mRNA Vaccines & Therapeutics Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America mRNA Vaccines & Therapeutics by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America mRNA Vaccines & Therapeutics Sales by Country (2015-2020)
  13.8.2 Latin America mRNA Vaccines & Therapeutics Consumption Value by Country (2015-2020)
13.9 Latin America mRNA Vaccines & Therapeutics Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa mRNA Vaccines & Therapeutics Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa mRNA Vaccines & Therapeutics Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa mRNA Vaccines & Therapeutics Production Analysis from 2015-2020
14.4 Middle East & Africa mRNA Vaccines & Therapeutics Consumption Analysis from 2015-2020
14.5 Middle East & Africa mRNA Vaccines & Therapeutics Import and Export from 2015-2020
14.6 Middle East & Africa mRNA Vaccines & Therapeutics Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa mRNA Vaccines & Therapeutics Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa mRNA Vaccines & Therapeutics by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2015-2020)
  14.8.2 Middle East & Africa mRNA Vaccines & Therapeutics Consumption Value by Country (2015-2020)
14.9 Middle East & Africa mRNA Vaccines & Therapeutics Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL MRNA VACCINES & THERAPEUTICS MARKET FROM 2020-2027

15.1 Future Forecast of the Global mRNA Vaccines & Therapeutics Market from 2020-2027 Segment by Region
15.2 Global mRNA Vaccines & Therapeutics Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global mRNA Vaccines & Therapeutics Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

LIST OF TABLES AND FIGURES

Global mRNA Vaccines & Therapeutics Market Value ($) and Growth Rate of mRNA Vaccines & Therapeutics from 2015-2027
Global mRNA Vaccines & Therapeutics Production and Growth Rate Segment by Product Type from 2015-2027
Global mRNA Vaccines & Therapeutics Consumption and Growth Rate Segment by Application from 2015-2027
Figure mRNA Vaccines & Therapeutics Picture
Table Product Specifications of mRNA Vaccines & Therapeutics
Table Driving Factors for this Market
Table Industry News of mRNA Vaccines & Therapeutics Market
Figure Value Chain Status of mRNA Vaccines & Therapeutics
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global mRNA Vaccines & Therapeutics Production and Growth Rate Segment by Product Type from 2015-2020
Table Global mRNA Vaccines & Therapeutics Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Standardization Of Cancer Treatment MRNA Vaccine of mRNA Vaccines & Therapeutics
Figure Individualized Cancer Treatment MRNA Vaccine of mRNA Vaccines & Therapeutics
Figure Infectious Disease Treatment MRNA Vaccine of mRNA Vaccines & Therapeutics
Figure Infection Prevention MRNA Vaccine of mRNA Vaccines & Therapeutics
Table Global mRNA Vaccines & Therapeutics Consumption and Growth Rate Segment by Application from 2015-2020
Table Global mRNA Vaccines & Therapeutics Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Hospital of mRNA Vaccines & Therapeutics
Figure Clinic of mRNA Vaccines & Therapeutics
Figure Others of mRNA Vaccines & Therapeutics
Table Global mRNA Vaccines & Therapeutics Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global mRNA Vaccines & Therapeutics Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of mRNA Vaccines & Therapeutics
Figure Online Channel of mRNA Vaccines & Therapeutics
Table Novartis Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis Sales and Growth Rate from 2015-2020
Figure Novartis Revenue ($) and Global Market Share from 2015-2020
Table Novartis mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Janssen Profile (Company Name, Plants Distribution, Sales Region)
Figure Janssen Sales and Growth Rate from 2015-2020
Figure Janssen Revenue ($) and Global Market Share from 2015-2020
Table Janssen mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Intellia Therapeutics Profile (Company Name, Plants Distribution, Sales Region)
Figure Intellia Therapeutics Sales and Growth Rate from 2015-2020
Figure Intellia Therapeutics Revenue ($) and Global Market Share from 2015-2020
Table Intellia Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Roche Custom Biotech Profile (Company Name, Plants Distribution, Sales Region)
Figure Roche Custom Biotech Sales and Growth Rate from 2015-2020
Figure Roche Custom Biotech Revenue ($) and Global Market Share from 2015-2020
Table Roche Custom Biotech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table RaNa Therapeutics Profile (Company Name, Plants Distribution, Sales Region)
Figure RaNa Therapeutics Sales and Growth Rate from 2015-2020
Figure RaNa Therapeutics Revenue ($) and Global Market Share from 2015-2020
Table RaNa Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table MaxCyte Profile (Company Name, Plants Distribution, Sales Region)
Figure MaxCyte Sales and Growth Rate from 2015-2020
Figure MaxCyte Revenue ($) and Global Market Share from 2015-2020
Table MaxCyte mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table CRISPR Therapeutics Profile (Company Name, Plants Distribution, Sales Region)
Figure CRISPR Therapeutics Sales and Growth Rate from 2015-2020
Figure CRISPR Therapeutics Revenue ($) and Global Market Share from 2015-2020
Table CRISPR Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table AstraZeneca Profile (Company Name, Plants Distribution, Sales Region)
Figure AstraZeneca Sales and Growth Rate from 2015-2020
Figure AstraZeneca Revenue ($) and Global Market Share from 2015-2020
Table AstraZeneca mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table PhaseRx Profile (Company Name, Plants Distribution, Sales Region)
Figure PhaseRx Sales and Growth Rate from 2015-2020
Figure PhaseRx Revenue ($) and Global Market Share from 2015-2020
Table PhaseRx mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Kernal Biologics Profile (Company Name, Plants Distribution, Sales Region)
Figure Kernal Biologics Sales and Growth Rate from 2015-2020
Figure Kernal Biologics Revenue ($) and Global Market Share from 2015-2020
Table Kernal Biologics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table GlaxoSmithKline Vaccines Profile (Company Name, Plants Distribution, Sales Region)
Figure GlaxoSmithKline Vaccines Sales and Growth Rate from 2015-2020
Figure GlaxoSmithKline Vaccines Revenue ($) and Global Market Share from 2015-2020
Table GlaxoSmithKline Vaccines mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Argos Therapeutics Profile (Company Name, Plants Distribution, Sales Region)
Figure Argos Therapeutics Sales and Growth Rate from 2015-2020
Figure Argos Therapeutics Revenue ($) and Global Market Share from 2015-2020
Table Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Boehringer Ingelheim Profile (Company Name, Plants Distribution, Sales Region)
Figure Boehringer Ingelheim Sales and Growth Rate from 2015-2020
Figure Boehringer Ingelheim Revenue ($) and Global Market Share from 2015-2020
Table Boehringer Ingelheim mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table ETheRNA immunotherapies Profile (Company Name, Plants Distribution, Sales Region)
Figure ETheRNA immunotherapies Sales and Growth Rate from 2015-2020
Figure ETheRNA immunotherapies Revenue ($) and Global Market Share from 2015-2020
Table ETheRNA immunotherapies mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Precision NanoSystems Profile (Company Name, Plants Distribution, Sales Region)
Figure Precision NanoSystems Sales and Growth Rate from 2015-2020
Figure Precision NanoSystems Revenue ($) and Global Market Share from 2015-2020
Table Precision NanoSystems mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Bayer Profile (Company Name, Plants Distribution, Sales Region)
Figure Bayer Sales and Growth Rate from 2015-2020
Figure Bayer Revenue ($) and Global Market Share from 2015-2020
Table Bayer mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table In-Cell-Art Profile (Company Name, Plants Distribution, Sales Region)
Figure In-Cell-Art Sales and Growth Rate from 2015-2020
Figure In-Cell-Art Revenue ($) and Global Market Share from 2015-2020
Table In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Moderna Therapeutics Profile (Company Name, Plants Distribution, Sales Region)
Figure Moderna Therapeutics Sales and Growth Rate from 2015-2020
Figure Moderna Therapeutics Revenue ($) and Global Market Share from 2015-2020
Table Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Ethris Profile (Company Name, Plants Distribution, Sales Region)
Figure Ethris Sales and Growth Rate from 2015-2020
Figure Ethris Revenue ($) and Global Market Share from 2015-2020
Table Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table CureVac Profile (Company Name, Plants Distribution, Sales Region)
Figure CureVac Sales and Growth Rate from 2015-2020
Figure CureVac Revenue ($) and Global Market Share from 2015-2020
Table CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table BioNTech Profile (Company Name, Plants Distribution, Sales Region)
Figure BioNTech Sales and Growth Rate from 2015-2020
Figure BioNTech Revenue ($) and Global Market Share from 2015-2020
Table BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global mRNA Vaccines & Therapeutics Production Value ($) by Region from 2015-2020
Table Global mRNA Vaccines & Therapeutics Production Value Share by Region from 2015-2020
Table Global mRNA Vaccines & Therapeutics Production by Region from 2015-2020
Table Global mRNA Vaccines & Therapeutics Consumption Value ($) by Region from 2015-2020
Table Global mRNA Vaccines & Therapeutics Consumption by Region from 2015-2020
Table North America mRNA Vaccines & Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America mRNA Vaccines & Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America mRNA Vaccines & Therapeutics Import and Export from 2015-2020
Table North America mRNA Vaccines & Therapeutics Value ($) by Type (2015-2020)
Table North America mRNA Vaccines & Therapeutics Production by Type (2015-2020)
Table North America mRNA Vaccines & Therapeutics Consumption by Application (2015-2020)
Table North America mRNA Vaccines & Therapeutics Consumption by Country (2015-2020)
Table North America mRNA Vaccines & Therapeutics Consumption Value ($) by Country (2015-2020)
Figure North America mRNA Vaccines & Therapeutics Market PEST Analysis
Table Europe mRNA Vaccines & Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe mRNA Vaccines & Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe mRNA Vaccines & Therapeutics Import and Export from 2015-2020
Table Europe mRNA Vaccines & Therapeutics Value ($) by Type (2015-2020)
Table Europe mRNA Vaccines & Therapeutics Production by Type (2015-2020)
Table Europe mRNA Vaccines & Therapeutics Consumption by Application (2015-2020)
Table Europe mRNA Vaccines & Therapeutics Consumption by Country (2015-2020)
Table Europe mRNA Vaccines & Therapeutics Consumption Value ($) by Country (2015-2020)
Figure Europe mRNA Vaccines & Therapeutics Market PEST Analysis
Table Asia-Pacific mRNA Vaccines & Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific mRNA Vaccines & Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific mRNA Vaccines & Therapeutics Import and Export from 2015-2020
Table Asia-Pacific mRNA Vaccines & Therapeutics Value ($) by Type (2015-2020)
Table Asia-Pacific mRNA Vaccines & Therapeutics Production by Type (2015-2020)
Table Asia-Pacific mRNA Vaccines & Therapeutics Consumption by Application (2015-2020)
Table Asia-Pacific mRNA Vaccines & Therapeutics Consumption by Country (2015-2020)
Table Asia-Pacific mRNA Vaccines & Therapeutics Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific mRNA Vaccines & Therapeutics Market PEST Analysis
Table Latin America mRNA Vaccines & Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America mRNA Vaccines & Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America mRNA Vaccines & Therapeutics Import and Export from 2015-2020
Table Latin America mRNA Vaccines & Therapeutics Value ($) by Type (2015-2020)
Table Latin America mRNA Vaccines & Therapeutics Production by Type (2015-2020)
Table Latin America mRNA Vaccines & Therapeutics Consumption by Application (2015-2020)
Table Latin America mRNA Vaccines & Therapeutics Consumption by Country (2015-2020)
Table Latin America mRNA Vaccines & Therapeutics Consumption Value ($) by Country (2015-2020)
Figure Latin America mRNA Vaccines & Therapeutics Market PEST Analysis
Table Middle East & Africa mRNA Vaccines & Therapeutics Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa mRNA Vaccines & Therapeutics Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa mRNA Vaccines & Therapeutics Import and Export from 2015-2020
Table Middle East & Africa mRNA Vaccines & Therapeutics Value ($) by Type (2015-2020)
Table Middle East & Africa mRNA Vaccines & Therapeutics Production by Type (2015-2020)
Table Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Application (2015-2020)
Table Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Country (2015-2020)
Table Middle East & Africa mRNA Vaccines & Therapeutics Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa mRNA Vaccines & Therapeutics Market PEST Analysis
Table Global mRNA Vaccines & Therapeutics Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global mRNA Vaccines & Therapeutics Production and Growth Rate Forecast by Region (2020-2027)
Table Global mRNA Vaccines & Therapeutics Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global mRNA Vaccines & Therapeutics Production and Growth Rate Forecast by Type (2020-2027)
Table Global mRNA Vaccines & Therapeutics Consumption and Growth Rate Forecast by Application (2020-2027)


More Publications